Richard Ding
Director/Miembro de la Junta en Aoran Biotechnology (Shanghai) Co. Ltd. .
Origen de la red de primer grado Richard Ding.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Aoran Biotechnology (Shanghai) Co. Ltd.
Aoran Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Aoran Biotechnology (Shanghai) Co. Ltd. is a biotechnology company based in Shanghai, China. Aoran Biotechnology specializes in molecular diagnostics. The Chinese company was founded in 2015 and the CEO is Chang Yu Jia.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Richard Ding a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
AKESO, INC. | Pharmaceuticals: Major | Director/Board Member | |
SHENZHEN YHLO BIOTECH CO., LTD. | Medical Specialties | Director/Board Member | |
Hengyang Normal University | College/University | Undergraduate Degree | |
Hunan Normal University | College/University | Graduate Degree | |
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Doctorate Degree | |
ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED | Medical Specialties | Director/Board Member | |
Genfleet Therapeutics (Shanghai), Inc.
Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member |
Estadísticas
Internacional
China | 6 |
Islas Caimán | 2 |
Hong-Kong | 2 |
Sectorial
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 2 |
Operativa
Director/Board Member | 9 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Las relaciones más conectadas
Insiders | |
---|---|
Yi Zhou | 8 |
Steve Jia | 1 |
Zheng Ping Du | 1 |
Xiao Xiang Lv | 1 |
Fei Luo | 1 |
Jian Xin Zhu | 1 |
- Bolsa de valores
- Insiders
- Richard Ding
- Conexiones Empresas